References
-
1a
Feroci M.
Inesi A.
Rossi L. In
Novel Trends in Electroorganic Synthesis
Torii S.
Springer-Verlag;
Tokio:
1998. and references cited therein
-
1b
Inesi A.
Mucciante V.
Rossi L.
J. Org. Chem.
1998,
63:
1337
-
1c
Feroci M.
Inesi A.
Mucciante V.
Rossi L.
Tetrahedron Lett.
1999,
40:
6059
-
1d
Mucciante V.
Rossi L.
Feroci M.
Sotgiu G.
Synth. Commun.
2002,
32:
1205
- 2
Ager DJ.
Prakash I.
Schaad DR.
Chem. Rev.
1996,
96:
835 ; and references cited therein
- 3 Dimroth P, and Pasedach H. inventors; (BASF) DE Pat 1164411.
; Chem. Abstr. 1964, 60, 14510
-
4a
Mitsudo T.
Hori Y.
Yamakawa Y.
Watanabe Y.
Tetrahedron Lett.
1987,
28:
4417
-
4b
Shi M.
Shen Y.-M.
J. Org. Chem.
2002,
67:
16
-
5a
Costa M.
Chiusoli GP.
Rizzardi M.
Chem. Commun.
1996,
1699
-
5b
Costa M.
Chiusoli GP.
Taffurelli D.
Dalmonego G.
J. Chem. Soc., Perkin Trans. 1
1998,
1541
- 6
Shi M.
Shen Y.-M.
Chen Y.-J.
Heterocycles
2002,
57:
245
- 7 TEAHC is simply obtained by saturating a methanol solution of tetraethylammonium hydroxide with CO2, see: Venturello C.
D’Aloisio R.
Synthesis
1985,
33
-
For further details concerning electrogeneration of TEAC, see:
-
8a
Casadei MA.
Inesi A.
Micheletti Moracci F.
Rossi L.
Chem. Commun.
1996,
2575
-
8b
Casadei MA.
Inesi A.
Rossi L.
Tetrahedron Lett.
1997,
38:
3565
-
9a
Imada Y.
Yuasa M.
Nakamura I.
Murahashi S.-I.
J. Org. Chem.
1994,
59:
2282
-
9b
N
-[2-(3,4-Dimethoxy-phenyl)ethyl]-2-methylbut-3-yn-2-amine (
1d): 1H NMR (200 MHz, CDCl3): δ = 1.36 (s, 6 H), 1.56 (br s, 1 H), 2.26 (s, 1 H), 2.78 (t, 2 H), 2.98 (t, 2 H), 3.87 (s, 3 H), 3.88 (s, 3 H), 6.65-6.85 (m, 5 H) ppm. 13C NMR (50.3 MHz, CDCl3): δ = 29.4, 35.9, 45.2, 49.6, 55.8, 55.9, 69.7, 88.8, 111.2, 111.8, 120.6, 132.2, 147.4, 148.8 ppm. Anal. Calcd: C, 72.84; H, 8.56. Found: C, 72.79; H, 8.54.
-
10a
Austin WB.
Bilow N.
Kelleghan WJ.
Lau KSY.
J. Org. Chem.
1981,
46:
2280
-
10b
Synthesis of 1-{4-[3-(benzylamino)-3-methylpent-1-ynyl]phenyl}ethanone (
1f): To a solution of 1c (1 g, 5.34 mmol) in DMF (2 mL), and Et3N (4 mL) were added 1-(4-iodophenyl)ethanone (1.315 g, 5.34 mmol), palladium diacetate (0.024 g, 0.107 mmol) and PPh3 (0.056 g, 0.213 mmol). The mixture was stirred under N2 at 50 °C for 16 h, then 0.5 M NH4Cl (100 mL) was added and the mixture extracted with Et2O (3 × 50 mL). The combined organic phase was dried (Na2SO4) and evaporated under reduced pressure. Silica gel chromatography (hexanes-EtOAc 90:10) afforded 1f (1.265 g, 78% yield). 1H NMR (200 MHz, CDCl3): δ = 1.08 (t, 3 H), 1.45 (s, 3 H), 1.48 (br s, 1 H), 1.74 (dq, 2 H), 2.59 (s, 3 H), 3.94 (s, 2 H), 7.20-7.45 (m, 5 H), 7.70 (AA′XX′, 4 H) ppm. 13C NMR (50.3 MHz, CDCl3): δ = 8.9, 26.3, 26.6, 34.6, 48.7, 54.7, 82.9, 97.5, 127.0, 128.2, 128.4, 128.5, 131.8, 135.9, 140.7, 197.4 ppm. Anal. Calcd: C, 82.58; H, 7.59. Found: C, 82.55; H, 7.56.
11 Some representative examples are reported:
4,4-Dimethyl-5-methylene-3-(3-phenylpropyl)-1,3-oxazolidin-2-one (
2b): 1H NMR (200 MHz, CDCl3): δ = 1.29 (s, 3 H), 1.80-2.00 (m, 2 H), 2.58 (t, 3 H), 3.11 (t, 3 H), 4.13 (dd, 1 H), 4.55 (dd, 1 H), 7.10-7.30 (m, 5 H) ppm. 13C NMR (50.3 MHz, CDCl3): δ = 27.5, 29.6, 30.9, 33.1, 40.0, 61.3, 83.9, 126.0, 128.2, 128.4, 141.0, 154.3, 160.6 ppm. Anal. Calcd: C, 73.44; H, 7.81. Found: C, 73.49; H, 7.73.
3-Benzyl-4-ethyl-4-methyl-5-methylene-1,3-oxazolidin-2-one (
2c): 1H NMR (200 MHz, CDCl3): δ = 0.65 (t, 3 H), 1.17 (s, 3 H), 1.30-1.55 (m, 1 H) 1.60-1.80 (m, 1 H), 4.09 (d, 1 H), 4.32 (AB, 2 H), 4.65 (d, 1 H), 7.15-7.35 (m, 5 H) ppm. 13C NMR (50.3 MHz, CDCl3): δ = 7.6, 27.3, 32.2, 44.0, 65.4, 84.5, 127.8, 128.1, 128.6, 137.4, 155.4, 158.8 ppm. Anal. Calcd: C, 72.70; H, 7.41. Found: C, 72.63; H, 7.29.
3-[2-(3,4-Dimethoxyphenyl)ethyl]-4,4-dimethyl-5-methylene-1,3-oxazolidin-2-one (
2d): 1H NMR (200 MHz, CDCl3): δ = 1.22 (s, 6 H), 2.75-2.95 (m, 2 H), 3.15-3.35 (m, 2 H), 3.78 (s, 3 H), 3.80 (s, 3 H), 4.12 (d, 1 H), 4.55 (d, 1 H), 6.60-6.80 (m, 3 H) ppm. 13C NMR (50.3 MHz, CDCl3): δ = 27.2, 34.5, 42.3, 55.8, 61.2, 84.0, 111.2, 112.0, 120.7, 130.9, 147.6, 148.8, 154.1, 160.5 ppm. Anal. Calcd: C, 65.96; H, 7.27. Found: C, 65.88; H, 7.14.
(5
Z
)-3-Benzyl-5-(4-methoxybenzylidene)-4,4-dimethyl-1,3-oxazolidin-2-one (
2h): 1H NMR (200 MHz, CDCl3):
δ = 1.27 (s, 6 H), 3.71 (s, 3 H), 4.41 (s, 2 H), 5.31 (s, 1 H), 6.70-6.85 (m, 2 H), 7.10-7.30 (m, 5 H), 7.40-7.55 (m, 2 H) ppm. 13C NMR (50.3 MHz, CDCl3): δ = 27.7, 44.0, 55.2, 62.3, 100.1, 113.8, 126.2, 127.7, 128.6, 129.5, 137.5, 151.6, 154.9, 158.3 ppm. Anal. Calcd: C, 74.28; H, 6.55. Found: C, 74.11; H, 6.38.
Methyl 3-[(3-Benzyl-4-ethyl-4-methyl-2-oxo-1,3-oxazolidin-5-ylidene)methyl]benzoate (
2i): 1H NMR (200 MHz, CDCl3): δ = 0.66 (t, 3 H), 1.18 (s, 3 H), 1.40-1.65 (m, 1 H), 1.70-1.95 (m, 1 H), 3.84 (s, 3 H), 4.38 (AB, 2 H), 5.37 (s, 1 H), 7.15-7.40 (m, 6 H), 7.75-8.10 (m, 3 H) ppm. 13C NMR (50.3 MHz, CDCl3): δ = 7.7, 27.3, 29.7, 44.1, 52.2, 66.3, 100.1, 127.8, 127.9, 128.1, 128.7, 129.4, 130.3, 132.5, 133.9, 137.2, 152.7, 155.1, 166.8 ppm. Anal. Calcd: C, 72.31; H, 6.34. Found: C, 72.39; H, 6.42.